This 2017 review examines the role of specific probiotic strains, particularly from the Lactobacillus and Bifidobacterium genera, in managing type 2 diabetes (T2D). It highlights that alterations in gut microbiota composition are associated with T2D and that probiotics may offer therapeutic benefits by modulating this microbiota. The review emphasizes the
This 2015 review discusses the taxonomic challenges and antibiotic susceptibility controversies surrounding Lactobacillus species. With over 170 species exhibiting phenotypic similarities, accurate identification often requires molecular methods. While generally considered non-pathogenic and used as probiotics, certain strains have been implicated in infections, particularly in immunocompromised individuals. The article highlights the
This 2021 observational study published in the International Journal of Endocrinology (PMID: 34257649) investigated the effects of inulin supplementation on insulin sensitivity and gut microbiota in individuals with prediabetes. Over six months, 49 participants consumed 15 g of inulin daily, resulting in significant improvements in insulin sensitivity, with reductions in
